FDA Misses Cannabinoid Lists Deadline as Hemp Rules Brace for Major Change
FDA failed to publish congressionally mandated lists of cannabinoids and to define what qualifies as a “container” for hemp products by the deadline, even as a November switch to a stricter hemp regime looms. The new rules would base legality on total THC (including delta-8) and other closely related cannabinoids, impose a per-container cap, and ban intermediates or non-naturally produced cannabinoids. Industry groups are pressing Congress to delay the ban and extend regulatory work, while alternatives like the HEMP Act seek to shape the forthcoming framework and testing/packaging requirements.
